ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation

J. Kwun,1 B. Ezekian,1 M. Manook,1 J. Park,1 J. Yoon,1 J. Sloan-Lancaster,2 C. Fortier,3 P. Rao,4 S. Knechtle.1

1Surgery, Duke University, Durham, NC
2Eli Lilly and Company, Indianapolis, IN, Canada
3PRCL Research Inc, Montreal, QC, Canada
4Synta Pharmaceuticals Inc., Lexington, MA.

Meeting: 2018 American Transplant Congress

Abstract number: D37

Keywords: Immunosuppression, Kidney transplantation, T cell activation

Session Information

Date: Tuesday, June 5, 2018

Session Name: Poster Session D: Immunosuppression Preclinical Studies

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Related Abstracts
  • CD28-Directed Therapy Prolongs Survival in a Non-Human Primate Kidney Transplant Model
  • DC-SIGN Functionalized Porous Silicon Nanoparticles Targeting to Human and Non-Human Primate Dendritic Cells.

[Background] Long-term administration of calcineurin inhibitors (CNIs) successfully controls rejection of transplanted organs. However, the chronic use of these drugs causes organ damage often resulting in serious kidney damage. Furthermore, chronic rejection of the transplant also occurs despite the use of these drugs. This study was conducted to determine the applicability of a new immunomodulatory drug directed to the calcium release-activated calcium (CRAC) channels of lymphocytes to control transplant rejection using a rhesus monkey renal transplantation model.

[Methods] Animals underwent kidney transplantation and were treated with tacrolimus alone (Target trough: 8-12 ng/ml; n=4), PRCL-02, a CRAC-M1 inhibitor (4-6mg/kg; n=4) alone, or initial tacrolimus with conversion to PRCL-02 (n=3). PRCL-02 was administered via a surgically inserted gastrostomy tube twice daily.

[Results] We determined the dose-related drug exposure in monkeys and then conducted renal transplants using PRCL-02. Oral dosing of PRCL2 (3~30mg/kg/day) was well tolerated. Animals treated with PRCL-02 showed suppressed T cell proliferation comparable to animals with tacrolimus treatment by in vitro MLR. All animals with tacrolimus monotherapy were sacrificed on day 100 without rejection. However, PRCL-02 monotherapy only marginally prolonged graft survival (MST=13.1 days) Animals treated with combined PRCL-02 with short-term (21 days) tacrolimus showed MST of 35.3 days, which was prolonged compared to PRCL-02 monotherapy but was not prolonged compared to the tacrolimus-treated group. Pharmacokinetic studies showed inconsistent drug exposures for unknown reasons, which may have contributed to the frequent rejections despite attempts to adjust dose and exposure.

[Conclusion] We conclude that PRCL-02 demonstrated some evidence of immunosuppressive activity but was inferior to tacrolimus with respect to suppressing immune rejection in this transplant model.

CITATION INFORMATION: Kwun J., Ezekian B., Manook M., Park J., Yoon J., Sloan-Lancaster J., Fortier C., Rao P., Knechtle S. Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kwun J, Ezekian B, Manook M, Park J, Yoon J, Sloan-Lancaster J, Fortier C, Rao P, Knechtle S. Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation [abstract]. https://atcmeetingabstracts.com/abstract/targeting-calcium-release-activated-calcium-crac-channel-in-non-human-primate-kidney-transplantation/. Accessed March 8, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.